Dualism of mixed chimerism between hematopoiesis and stroma in chronic idiopathic myelofibrosis after allogeneic stem cell transplantation

Histology and Histopathology

Volumn 22, Issue 4-6, 2007, Pages 365-372

  Thiele, Juergen ^a   Varus, E ^a   Siebolts, U ^a   Kvasnicka, H M ^a   Wickenhauser, C ^a   Metz, K A ^b   Beelen, D W ^b   Ditschkowski, M ^b   Zander, A ^c   Kroger N ^c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Bone marrow biopsies; CD34+ progenitors; Chronic idiopathic myelofibrosis; Endothelial cells; Megakaryocytes; Mixed chimerism; Peripheral stem cell transplantation

Indexed keywords

BUSULFAN; CD34 ANTIGEN; CD61 ANTIGEN; HYDROXYUREA; MYELOABLATIVE AGENT;

ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; CD34 SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; ENDOTHELIUM CELL; ENGRAFTMENT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOTYPE; HEMATOPOIESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; MALE; MEGAKARYOCYTE; MIXED CHIMERA; MYELOABLATIVE CONDITIONING; MYELOID METAPLASIA; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; STROMA CELL; VASCULAR ENDOTHELIUM; ALLOTRANSPLANTATION; BONE MARROW CELL; HISTOCOMPATIBILITY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MYELOFIBROSIS; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; STEM CELL TRANSPLANTATION;

ANTIGENS, CD34; BONE MARROW CELLS; ENDOTHELIUM, VASCULAR; FEMALE; GENOTYPE; HEMATOPOIESIS; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MYELOFIBROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; STEM CELLS; STROMAL CELLS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 33947501575     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Agematsu K. and Nakahori Y. (1991). Recipient origin of bone marrow-derived fibroblastic stromal cells during all periods following bone marrow transplantation in humans. Br. J. Haematol. 79, 359-365.
2. Alizadeh M, Bernard M., Danic B., Dauriac C., Birebent B., Lapart C., Lamy T., Le Prise P.Y., Beauplet A., Bories D., Semana G. and Quelvennec E. (2002). Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood 99, 4618-4625.
3. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G. and Isner J.M. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967.
4. Athanasou N.A., Quinn J., Brenner M.K., Prentice H.G., Graham A., Taylor S., Flannery D. and McGee J.O. (1990). Origin of marrow stromal cells and haemopoietic chimaerism following bone marrow transplantation determined by in situ hybridisation. Br. J. Cancer 61, 385-389.
5. Bull J.H. and Harnden P. (1999). Efficient nuclear FISH on paraffin-embedded tissue sections using microwave pretreatment. Biotechniques 26, 416-418, 422.
6. Choi K., Kennedy M., Kazarov A., Papadimitriou J.C. and Keller G. (1998). A common precursor for hematopoietic and endothelial cells. Development 125, 725-732.
7. Chomel J.C., Brizard F., Veinstein A., Rivet J., Sadoun A., Kitzis A., Guilhot F. and Brizard A. (2000). Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantation. Blood 95, 404-408.
8. Cordell J.L., Falini B., Erber W.N., Ghosh A.K., Abdulaziz Z., MacDonald S., Pulford K.A., Stein H. and Mason D.Y. (1984). Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 32, 219-229.
9. Davis T.A., Robinson D.H., Lee K.P. and Kessler S.W. (1995). Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: requirement for cell-to-cell interactions and colony-stimulating factors. Blood 85, 1751-1761.
10. Deeg H.J., Gooley T.A., Flowers M.E., Sale G.E., Slattery J.T., Anasetti C., Chauncey T.R., Doney K., Georges G.E., Kiem H.P., Martin P.J., Petersdorf E.W., Radich J., Sanders J.E., Sandmaier B.M., Warren E.H., Witherspoon R.P., Storb R. and Appelbaum F.R. (2003). Allogeneic hematopoietic stem cell transplantation for myelofibrosis. Blood 102, 3912-3918.
11. Elmaagacli A.H., Runkel K., Steckel N., Opalka B., Trenschel R., Seeber S., Schaefer U.W. and Beelen D.W. (2001). A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase. Bone Marrow Transplant. 27, 809-815.
12. Fehse B., Chukhlovin A., Kuhlcke K., Marinetz O., Vorwig O., Renges H., Kruger W., Zabelina T., Dudina O., Finckenstein F.G., Kroger N., Kabisch H., Hochhaus A. and Zander A.R. (2001). Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation. J. Hematother. Stem. Cell Res. 10, 419-425.
13. Gatter K.C., Cordell J.L., Turley H., Heryet A., Kieffer N., Anstee D.J. and Mason D.Y. (1988). The immunohistological detection of platelets, megakaryocytes and thrombi in routinely processed specimens. Histopathology 13, 257-267.
14. Gehling U.M., Ergun S., Schumacher U., Wagener C., Pantel K., Otte M., Schuch G., Schafhausen P., Mende T., Kilic N., Kluge K., Schafer B., Hossfeld D.K. and Fiedler W. (2000). In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95, 3106-3112.
15. Golde D.W., Hocking W.G., Quan S.G., Sparkes R.S. and Gale R.P. (1980). Origin of human bone marrow fibroblasts. Br. J. Haematol. 44, 183-187.
16. Greenberg B.R., Wilson F.D., Woo L. and Jenks H.M. (1978). Cytogentics of fibroblastic colonies in Ph1-positive chronic myelogenous leukemia. Blood 51, 1039-1044.
17. Gunsilius E., Duba H.C., Petzer A.L., Kahler C.M., Grunewald K., Stockhammer G., Gabl C., Dirnhofer S., Clausen J. and Gastl G. (2000). Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 355, 1688-1691.
18. Holyoake T., Jiang X., Eaves C. and Eaves A. (1999). Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood 94, 2056-2064.
19. Hristov M. and Weber C. (2004). Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J. Cell. Mol. Med. 8, 498-508.
20. Iwami Y., Masuda H. and Asahara T. (2004). Endothelial progenitor cells: past, state of the art, and future. J. Cell. Mol. Med. 8, 488-497.
21. Kitzis A., Brizard F., Dascalescu C., Chomel J.C., Guilhot F. and Brizard A. (2001). Persistence of transcriptionally silent BCR-ABL rearrangements in chronic myeloid leukemia patients in sustained complete cytogenetic remission. Leuk. Lymphoma 42, 933-944.
22. Koegler G., Wolf H.H., Heyll A., Arkesteijn G. and Wernet P. (1995). Detection of mixed chimerism and leukemic relapse after allogeneic bone marrow transplantation in subpopulations of leucocytes by fluorescent in situ hybridization in combination with the simultaneous immunophenotypic analysis of interphase cells. Bone Marrow Transplant. 15, 41-48.
23. Kröger N., Zabelina T., Schieder H., Panse J., Ayuk F., Stute N., Fehse N., Waschke O., Fehse B., Kvasnicka H.M., Thiele J. and Zander A. (2005). Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis. Br. J. Haematol. 128, 690-697.
24. Kvasnicka H.M. and Thiele J. (2004). Bone marrow angiogenesis: methods of quantification and changes evolving in chronic myeloproliferative disorders. Histol. Histopathol. 19, 1245-1260.
25. Kvasnicka H.M., Wickenhauser C., Thiele J., Varus E., Hamm K., Beelen D.W. and Schaefer U.W. (2003). Mixed chimerism of bone marrow vessels (endothelial cells, myofibroblasts) following allogeneic transplantation for chronic myelogenous leukemia. Leuk. Lymphoma 44, 321-328.
26. Mackinnon S., Barnett L., Heller G. and O'Reilly R.J. (1994). Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood 83, 3409-3416.
27. Mohle R., Bautz F., Rafii S., Moore M.A., Brugger W. and Kanz L. (1999). Regulation of transendothelial migration of hematopoietic progenitor cells. Ann. NY Acad. Sci. 872, 176-186.
28. Murasawa S. and Asahara T. (2005). Endothelial progenitor cells for vasculogenesis. Physiology (Bethesda) 20, 36-42.
29. O'Brien S., Kantarjian H., Shtalrid M., Blick M., Beran M. and Talpaz M. (1988). Lack of breakpoint cluster region rearrangement in marrow fibroblasts of patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Hematol. Pathol. 2, 25-29.
30. Oka T., Sastry K.J., Nehete P., Schapiro S.J., Guo J.Q., Talpaz M. and Arlinghaus R.B. (1998). Evidence for specific immune response against P210 BCR-ABL in long-term remission CML patients treated with interferon. Leukemia 12, 155-163.
31. Rafii S., Shapiro F., Pettengell R., Ferris B., Nachman R.L., Moore M.A. and Asch A.S. (1995). Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood 86, 3353-3363.
32. Reilly J.T., Nash J.R., Mackie M.J. and McVerry B.A. (1985). Endothelial cell proliferation in myelofibrosis. Br. J. Haematol. 60, 625-630.
33. Rondelli D., Barosi G., Bacigalupo A., Prchal J.T., Popat U., Alessandrino E.P., Spivak J.L., Smith B.D., Klingemann H.G., Fruchtman S. and Hoffman R. (2005). Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia. Blood 105, 4115-4119.
34. Rondon G., Giralt S., Pereira M., Van Besien K., Mehra R., Champlin R. and Andreeff M. (1997). Analysis of chimerism following allogeneic bone marrow transplantation by fluorescent-in-situ hybridization. Leuk. Lymphoma 25, 463-467.
35. Santucci M.A., Trabetti E., Martinelli G., Buzzi M., Zaccaria A., Pileri S., Farabegoli P., Sabattini E., Tura S. and Pignatti P.F. (1992). Host origin of bone marrow fibroblasts following allogeneic bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant. 10, 255-259.
36. Schatteman G.C. (2004). Adult bone marrow-derived hemangioblasts, endothelial cell progenitors, and EPCs. Curr. Top. Dev. Biol. 64, 141-180.
37. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L. and Schuh A.C. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66.
38. Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C., Ishida A., Fujita Y., Kothari S., Mohle R., Sauvage L.R., Moore M.A., Storb R.F. and Hammond W.P. (1998). Evidence for circulating bone marrow-derived endothelial cells. Blood 92, 362-367.
39. Simmons P.J., Przepiorka D., Thomas E.D. and Torok-Storb B. (1987). Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 328, 429-432.
40. Simmons P.J., Masinovsky B., Longenecker B.M., Berenson R., Torok-Storb B. and Gallatin W.M. (1992). Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 80, 388-395.
41. Smith A., Robson L.G., Sharma P. and Shaw P.J. (1999). Application of interphase FISH on direct bone marrow smears for evidence of chimerism in pediatric sex mismatched bone marrow transplantation. Pathology 31, 25-28.
42. Soligo D., Delia D., Oriani A., Cattoretti G., Orazi A., Bertolli V., Quirici N. and Deliliers G.L. (1991). Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody. Leukemia 5, 1026-1030.
43. Tamura S., Saheki K., Takatsuka H., Wada H., Fujimori Y., Okamoto T., Takemoto Y., Hashimoto-Tamaoki T., Furuyama J. and Kakishita E. (2000). Early detection of relapse and evaluation of treatment for mixed chimerism using fluorescence in situ hybridization following allogeneic hematopoietic cell transplant for hematological malignancies. Ann. Hematol. 79, 622-626.
44. Thiede C., Florek M., Bornhauser M., Ritter M., Mohr B., Brendel C., Ehninger G. and Neubauer A. (1999). Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant. 23, 1055-1060.
45. Thiede C., Bornhauser M. and Ehninger G. (2004). Strategies and clinical implications of chimerism diagnostics after allogeneic hematopoietic stem cell transplantation. Acta Haematol. 112, 16-23.
46. Thiele J., Rompcik V., Wagner S. and Fischer R. (1992). Vascular architecture and collagen type IV in primary myelofibrosis and polycythaemia vera: an immunomorphometric study on trephine biopsies of the bone marrow. Br. J. Haematol. 80, 227-234.
47. Thiele J., Imbert M., Pierre R., Vardiman J.W., Brunning R.D. and Flandrin G. (2001). Chronic idiopathic myelofibrosis. In WHO Classification of Tumours: Tumours of Haematopoietic and Lymphoid Tissues. Jaffe E.S., Harris N.L., Stein H. and Vardiman J.W. (eds) IARC Press. Lyon. pp. 35-38.
48. Uhr J.W., Scheuermann R.H., Street N.E. and Vitetta E.S. (1997). Cancer dormancy: opportunities for new therapeutic approaches. Nat. Med. 3, 505-509.
49. van Besien K. and Deeg H.J. (2005). Hematopoietic Stem Cell Transplantation for Myelofibrosis. Semin. Oncol. 32, 414-421.
50. White A.D. and Sweeney M.C. (1993). Detection of male cells in mixtures containing varying proportions of male and female cells by fluorescence in situ hybridization and G-banding. Cytometry 14, 9-15.